Lords Mark Industries has become the first and only company in India to receive a manufacturing licence for an In Vitro Diagnostic Software (Software as a Medical Device - SaMD) for its Biomescan Analytics Platform. The licence has been granted under the Medical Devices Rules, 2017, marking a significant step in bringing gut microbiome science into mainstream wellness and preventive healthcare.
Biomescan combines whole metagenome sequencing data with a validated bioinformatics pipeline to generate detailed gut microbiome profiles, diversity scores, enterotype classification, functional metabolic assessments, and evidence-based personalized dietary recommendations.
With this, the company plans to establish a nationwide network of Health & Wellness Centres in collaboration with hospitals, doctors, and healthcare institutions to provide personalized microbiome assessments and preventive care strategies.
Lords Mark Industries is engaged in consultancy in various fields including trading in capital market instruments; market research and follow-up across multiple industries; turnkey power projects consultancy; and undertaking energy and infrastructure projects.
